Xencor | XNCR - Ebit

Stock Price
11.86
Daily Change
0.29 2.51%
Monthly
-8.91%
Yearly
-17.92%
Q1 Forecast
11.06

Xencor reported $-47.52M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Arrowhead Research USD 40.81M 17.01M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Karyopharm Therapeutics USD -26.28M 1.84M Sep/2024
MacroGenics USD 20.16M 55.51M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Xencor USD -47.52M 24.69M Sep/2025